CISPLATIN AS 1ST-LINE THERAPY FOR METASTATIC BREAST-CANCER

被引：194

作者：

SLEDGE, GW

LOEHRER, PJ

ROTH, BJ

EINHORN, LH

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 12期

关键词：

D O I：

10.1200/JCO.1988.6.12.1811

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1811 / 1814

页数：4

共 12 条

[1] THE EFFECT ON SURVIVAL OF INITIAL CHEMOTHERAPY IN ADVANCED BREAST-CANCER - POLYCHEMOTHERAPY VERSUS SINGLE DRUG [J].

AHMANN, DL ;

SCHAID, DJ ;

BISEL, HF ;

HAHN, RG ;

EDMONSON, JH ;

INGLE, JN .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1928-1932

[2] A PHASE-III CLINICAL-TRIAL COMPARING THE COMBINATION CYCLOPHOSPHAMIDE, ADRIAMYCIN, CISPLATIN WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, PREDNISONE IN PATIENTS WITH ADVANCED BREAST-CANCER [J].

CREAGAN, ET ;

GREEN, SJ ;

AHMANN, DL ;

INGLE, JN ;

EDMONSON, JH ;

MARSCHKE, RF .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) :1260-1265

[3] CISPLATIN IN THE TREATMENT OF METASTATIC BREAST-CARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL OF 2 DOSAGE SCHEDULES [J].

FORASTIERE, AA ;

HAKES, TB ;

WITTES, JT ;

WITTES, RE .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (03) :243-247

[4]

HENDERSON IC, 1983, CANCER, V51, P2553, DOI 10.1002/1097-0142(19830615)51:12+<2553::AID-CNCR2820511329>3.0.CO

[5]

2-7

[6] PHASE-II CLINICAL-TRIAL OF CIS-DICHLORODIAMMINE PLATINUM (CIS-DDP) FOR ANTITUMORIGENIC ACTIVITY IN PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC BREAST-CANCER [J].

KOLARIC, K ;

ROTH, A .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (02) :108-112

[7]

KOLARIC K, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P77

[8] A PHASE-II STUDY OF CIS-DIAMMINEDICHLOROPLATINUM-II FOR ADVANCED BREAST-CANCER 2 DOSE SCHEDULES [J].

MARTINO, S ;

SAMAL, BA ;

SINGHAKOWINTA, A ;

YOSHIDA, S ;

MACKENZIE, M ;

JAIN, J ;

VAITKEVICIUS, VK .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 108 (03) :354-356

[9]

MECHL Z, 1984, NEOPLASMA, V31, P431

[10]

WILSON KS, 1986, CANCER TREAT REP, V70, P1021

← 1 2 →